RedHotStocks

PURA Sees 87% Growth In Sales. Bullish Reversal Imminent.

Long
OTC:PURA   Puration Inc.
=====================
Puration, Inc. (PURA)

Alert Price: $0.046

Price Target: $0.25 (Goldman Small Cap Research)

finance.yahoo.com/ne...nding-130120180.html

Float: 537.8M

Website | Recent News
========================


Members,

We've found another great CBD sector opportunity trading on the OTC.

The company has witnessed growth of 87% and has a chart that is trending bullish.

Please turn your immediate attention to Puration Inc. (PURA).

PURA is already a leading CBD infused beverage company having produced over $1 million in CBD Beverages in the United States last year (2018) and reporting over $1 million in CBD Beverages for just the first six months of 2019. PURA has targeted $4 million in sales for 2019.

finance.yahoo.com/quote/PURA?p=PURA&...

Company Highlights
87% Growth To Over $1 Million In Sales For 1st Six Months Of 2019
Sales On Track To Reach $4 Million 2019 Revenue Target
Launched a pre-marketing campaign of its new CBD Infused beer, coffee and tea beverages.
Plans to publish results from the previously announced CBD infused beverage market survey
A first mover in the CBD sports market. Already ahead of CBD giant Aurora Cannabis
Recently announced the launch of its EVERx CBD Sports Water marketing campaign in Europe.
Goldman Small Cap Research recently released a new research report recommending PURA as a Speculative BUY with a $0.25 PPS Target.
EVERx today is the leading CBD infused sports nutrition beverage with over $1 million in sales in 2018 and over $1 million in sales in the first six months of 2019 and targeting $4 million in sales by 2019 year end. EVERx is now an official sponsor of Jan Tana's Body Painting Revolution featured globally at Arnold Sports Festival venues worldwide.
EVERx CBD Sports Water is available for purchase on line at www.USMJ.com hosted by PURA's partner North American Cannabis Holdings, Inc. (USMJ).

PURA's Chart Is Trending Bullish

Based on our very own chart analysis, we see the potential for a nice move to the upside for PURA.

Bullish Trendline Support
Bullish 7 & 12 MA Crossing
MA's now new support. Trendline remains bullish.
Buy side volume increasing, sellers dwindling
Stoch has reset and is now in bullish reversal
PURA Will Soon Be Grabbing The Full Attention Of Wall St.

The company plans to publish results from the previously announced CBD infused beverage market survey tomorrow, Wednesday, September 18, 2019. The survey has been conducted by Goldman Small Cap Research. The survey is part of a pre-marketing campaign of PURA’s new CBD Infused beer, coffee and tea beverages. The data collected will be used to target PURA’s marketing direction for CBD infused beer, coffee and tea.

PURA recently implemented program to introduce CBD infused versions of existing third-party beverages. The company has announced plans to introduce a CBD infused beer in partnership with an existing beer producer and in similar fashion, PURA has partnered with an existing coffee producer and tea producer to introduce CBD infused coffee and tea. The company recently published a presentation on its beer, coffee and tea initiative that is included in its entirety on the company’s website.

Source: finance.yahoo.com/ne...e-cbd-124642564.html

PURA 2019 $4 Million Revenue Target On Track And Shareholders Are One Big Step Closer To Receiving Stock Dividend
PURA Reports 87% Growth To Over $1 Million In Sales For 1st Six Months Of 2019
PURA Posts $122,000 Net Income From Operations
Sales On Track To Reach $4 Million 2019 Revenue Target
NOUV Issues Preferred Stock To PURA For PURA Shareholder Dividend
In August the Company published a management update in conjunction with the recently published 2019 Q2 Financial Report. The company reported over $1 million in revenue for the first six months of 2019. The 2019 revenue for the first six months of 2019 is 87% higher than the revenue reported for the same period in 2018. The company also posted $122,000 in net income from operations for the first six months of 2019.

CEO Brian Shibley Update:

PURA has announced a $4 million revenue target for 2019. The company broke $1 million in sales for the 2018 fiscal year. I believe the Q2 2019 report demonstrates that the company can reach its $4 million revenue target.

I actually believe sales could have been even higher in the first six months of 2019. We had reached production capacity on our EVERx CBD Sports Water and spent considerable time and effort in the first half of the year overcoming our production constraints. Had we not been constrained, I believe we would have realized more sales in the first two quarters. We simply could not make enough EVERx to satisfy demand. Now the constraints are off and I expect we will see substantial EVERx sales growth in the second half of 2019.

We did get our production capacity under wraps in time to realize the first phase of an order for a private labeled CBD infused water. That gave us a nice boost in sales. However, it also came with an added expense. Both the expense of expanding our production capacity and setting up production for a private labeled product took a toll on our margins. However, that added expense is not recurring and we anticipate improved margins in the following two quarters of this year.

In addition to our revenue growth and the outlook for continued revenue growth and improving margins, PURA also took a big step forward recently on the issuance of the Nouveau, Inc. (NOUV) stock dividend intended for distribution to PURA shareholders. PURA spun-off its cannabis cultivation operation last year to NOUV in a deal that includes a planned distribution of NOUV stock to PURA shareholders. The orchestration of such a dividend issuance is not trivial. It takes some time to get it executed. You will notice on the most recent financial report that NOUV has recently issued preferred stock to PURA. We will in turn distribute the NOUV stock soon to PURA shareholders in a dividend distribution.

Source: finance.yahoo.com/ne...llion-130000709.html

PURA Is A First Mover In The CBD Sports Market. Already Ahead Of Aurora Cannabis
Pura today complimented Aurora Cannabis on its strategy to pursue the legal hemp derived CBD market in the United States (US). Aurora Cannabis has just announced plans to pursue the legal hemp derived CBD opportunity in the US focusing first on the sports market where PURA has already made a name for itself. Aurora Cannabis has entered into a clinical research partnership with the UFC (Ultimate Fighting Championship). Aurora Cannabis has voiced its intention on assessing CBD’s potential for treating sports related pain and aiding recovery. PURA has been focused on the sports nutrition market since its introduction of EVERx CBD Sports Water at Arnold Schwarzenegger’s Arnold Sports Festival in 2017. EVERx has sponsored multiple MMA (mixed martial arts events) to include sponsoring UFC fighters. EVERx has worked with UFC Fighter Julianna Pena, UFC Fighter Cee Jay Hamilton and two-time Super Bowl quarterback champion Jim McMahon. PURA is the sole licensee of Kali-Extracts (KALY) patented cannabis extraction process and has access to KALY’s extensive research on various applications of CBD extracts. PURA has gone global with its marketing of EVERx CBD Sports Water participating in the Arnold Sports Festival worldwide. PURA is launching a European EVERx CBD Sports Water marketing campaign this week at the Arnold Sports Festival in Barcelona, Spain. PURA management views Aurora Cannabis’s US Strategy on target and a validation of PURA’s long-term strategy.

PURA is already a leading CBD infused beverage company having produced over $1 million in CBD Beverages in the United States last year (2018) and reporting over $1 million in CBD Beverages for just the first six months of 2019. PURA has targeted $4 million in sales for 2019.

EVERx CBD Sports Water is available for purchase on line at www.USMJ.com.

Source: finance.yahoo.com/ne...ahead-132800581.html

PURA Speculative Buy Recommendation and $0.25 PPS Target w/Potential to $0.35

Goldman Small Cap Research recently released a new research report recommending PURA as a Speculative BUY with a $0.25 PPS Target. Goldman Small Cap Research further reports that the shares of PURA “have the potential to reach the $0.35 mark.” The report highlights PURA’s growing EVERx CBD Sports Water sales and the coming introduction of new beverages as well as the potential for the company to exceed its 2019 sales targets through the pending doubling of its production capacity and through planned acquisitions. The report further details recent updates intended to accelerate the issue of Nouveau (NOUV) stock to PURA shareholders in a dividend distribution. Notably, the report points to the capacity and quality improvements enabled by the addition of a new team member with exceptional beverage industry professional experience.

Source: finance.yahoo.com/ne...nding-130120180.html

About Puration Inc.

PURA is already a leading CBD infused beverage company having produced over $1 million in CBD Beverages in the United States last year (2018) and reporting over $1 million in CBD Beverages for just the first six months of 2019. PURA has targeted $4 million in sales for 2019.

For more information on Puration, visit www.purationinc.com

(*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.)



DISCLAIMER

This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.

We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future.



MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated ten thousand dollars by STM LLC to conduct investor relations advertising and marketing for PURA. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.


We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.





Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.